Withdrawn

2

225

Europe

Nicotinamide, Placebo

RWTH Aachen University, Assistance Publique - Hôpitaux de Paris

Friedreich Ataxia

06/25

12/25

Recruiting

1/2

65

Europe, RoW

VO659

Vico Therapeutics B. V., VICO Therapeutics B.V.

Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease

09/25

09/25

Active, not recruiting

N/A

200

US

The Methodist Hospital Research Institute, University of Michigan, University of Minnesota, University of Utah, University of California, Los Angeles, University of Chicago, University of South Florida, Harvard University, Johns Hopkins University, University of Florida, Columbia University, Emory University, University of California, San Francisco, University of Alabama at Birmingham, University of Colorado, Denver, University of Rochester, Stanford University, Northwestern University, German Center for Neurodegenerative Diseases (DZNE), Institut de Recherche sur la Moelle épinière et l'Encéphale, University of Pennsylvania, Ohio State University, University of Iowa

Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia 3

12/23

12/23

Recruiting

N/A

1200

Europe, RoW

European Friedreich's Ataxia Consortium for Translational Studies

Friedreich's Ataxia

12/24

12/24

Recruiting

N/A

3000

Europe, Canada, US, RoW

Friedreich's Ataxia Research Alliance

Friedreich Ataxia

01/48

01/48